2024-02-20 12:58:03 ET
Medtronic plc (MDT)
Q3 2024 Earnings Conference Call
February 20, 2024, 8:00 AM ET
Company Participants
Ryan Weispfenning - Vice President and Head, Investor Relations
Geoff Martha - Chairman and Chief Executive Officer
Karen Parkhill - Chief Financial Officer
Brad Welnick - Vice President, Investor Relations
Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio
Que Dallara - Executive Vice President and President, Diabetes
Mike Marinaro - Executive Vice President and President, Medical-Surgical Portfolio
Conference Call Participants
Larry Biegelsen - Wells Fargo
Robert Marcus - JPMorgan
Joanne Wuensch - Citi
Travis Steed - Bank of America
Vijay Kumar - Evercore ISI
Matt Miksic - Barclays
Anthony Petrone - Mizuho Securities
Presentation
Ryan Weispfenning
[Video Presentation]
Good morning and welcome to Minnesota, where we finally have some snow. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. And I appreciate that you're joining us this morning for our Fiscal '24 Third Quarter Video Earnings Webcast.
Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Geoff Martha, Medtronic's Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic's Chief Financial Officer.
Geoff and Karen will provide comments on the results of our third quarter, which ended on January 26th, 2024, and our outlook for the remainder of the fiscal year. After our prepared remarks, the Executive VPs covering our segments will join us. And we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour.
Earlier this morning, we issued a press release containing our financial statements and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com.
During today's program, many of the statements we make may be considered forward-looking statements. And actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC. And we do not undertake to update any forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
Medtronic plc (MDT) Q3 2024 Earnings Call Transcript